SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-22-001505
Filing Date
2022-02-11
Accepted
2022-02-11 08:19:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROTALIX BIOTHERAPEUTICS, INC. p22-0847sc13ga.htm SC 13G/A 48748
  Complete submission text file 0000902664-22-001505.txt   50678
Mailing Address 277 PARK AVE 23RD FLOOR NEW YORK NY 10172
Business Address 277 PARK AVE 23RD FLOOR NEW YORK NY 10172 2122872500
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

IRS No.: 134131516 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 22616879
SIC: 2836 Biological Products, (No Diagnostic Substances)